购物车
全部删除
您的购物车当前为空
别名 TYA018, TYA 018
TYA-018 是一种可口服且具有选择性的 HDAC6 抑制剂,具有心脏保护作用,可用于研究扩张性心脏病和心力衰竭。TYA-018 可防止肌节损伤并降低 Nppb 表达。


为众多的药物研发团队赋能,
让新药发现更简单!
TYA-018 是一种可口服且具有选择性的 HDAC6 抑制剂,具有心脏保护作用,可用于研究扩张性心脏病和心力衰竭。TYA-018 可防止肌节损伤并降低 Nppb 表达。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,820 | 现货 | |
| 5 mg | ¥ 4,630 | 现货 | |
| 10 mg | ¥ 6,490 | 现货 | |
| 25 mg | ¥ 9,630 | 现货 | |
| 50 mg | ¥ 12,900 | 现货 | |
| 100 mg | ¥ 17,500 | 现货 |
TYA-018 相关产品
| 产品描述 | TYA-018 is an orally available and selective HDAC6 inhibitor with cardioprotective properties for the study of dilated heart disease and heart failure.TYA-018 prevents sarcomere damage and decreases Nppb expression. |
| 体内活性 | In BAG3cKO mice, TYA-018 (15 mg/kg; oral gavage, daily, starting at 2 months old, for 8 weeks) conferred cardioprotection in mice. It significantly reduced Nppb expression to near wild-type levels. |
| 别名 | TYA018, TYA 018 |
| 分子量 | 434.87 |
| 分子式 | C15H13ClF2N4O3S2 |
| CAS No. | 2653254-31-8 |
| Smiles | O=S(=O)(N(C=1C=CC=C(Cl)C1)CC2=NC=C(S2)C3=NN=C(O3)C(F)F)CC |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (183.96 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.59 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容